المؤلفون: Philippe Moreau, Ajai Chari, Albert Oriol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikander Ailawadhi, Britta Besemer, Javier de la Rubia Comos, Cristina Encinas, Maria-Victoria Mateos, Hans Salwender, Paula Rodriguez-Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosiñol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt

المصدر: Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2044-5385

URL الوصول: https://doaj.org/article/8ddf4818d05d49919016d3e65c55a1f9

المؤلفون: Saad Z. Usmani, Hareth Nahi, Wojciech Legiec, Sebastian Grosicki, Vladimir Vorobyev, Ivan Spicka, Vania Hungria, Sibirina Korenkova, Nizar J. Bahlis, Max Flogegard, Joan Bladé, Philippe Moreau, Martin Kaiser, Shinsuke Iida, Jacob Laubach, Hila Magen, Michele Cavo, Cyrille Hulin, Darrell White, Valerio De Stefano, Kristen Lantz, Lisa O’Rourke, Christoph Heuck, Maria Delioukina, Xiang Qin, Ivo Nnane, Ming Qi, Maria-Victoria Mateos

المصدر: Haematologica, Vol 107, Iss 10 (2022)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://haematologica.org/article/view/10587; https://doaj.org/toc/0390-6078; https://doaj.org/toc/1592-8721

URL الوصول: https://doaj.org/article/c2850abc3ea941e8857efb2bc647357e

المؤلفون: Maria-Victoria Mateos, Sophie Rigaudeau, Supratik Basu, Ivan Spicka, Rik Schots, Tomasz Wrobel, Gordon Cook, Meral Beksac, Katharine S Gries, Anupa Kudva, Brenda Tromp, Rian Van Rampelbergh, Huiling Pei, Susan Wroblewski, Robin Carson, Maria Delioukina, Darrell White

المساهمون: Clinical sciences, Hematology

مصطلحات موضوعية: multiple myeloma, hematology, intravenous, oncology, Pharmacology (medical), subcutaneous, transplant-ineligible, daratumumab

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bacbd973ef3583b7c1d5c40ab6d1735b
https://hdl.handle.net/20.500.14017/1d6168cb-e413-4fc4-a468-ac4c8d8875d8

المؤلفون: Shaji Kumar, Maria Delioukina, Torben Plesner, Noopur Raje, Jessica Vermeulen, Hartmut Goldschmidt, Supratik Basu, Hang Quach, Rian Van Rampelbergh, Saad Z. Usmani, Xavier Leleu, Aurore Perrot, Thierry Facon, Jianping Wang, Tahamtan Ahmadi, Michael O'Dwyer, Clarissa M. Uhlar, Katja Weisel, Cyrille Hulin, Robert Z. Orlowski, Brenda Tromp, Philippe Moreau, Christopher P. Venner, Joseph R. Mace, Mourad Tiab, Margaret Macro, Laurent Frenzel, Hareth Nahi, Nizar J. Bahlis

المصدر: Facon, T, Kumar, S K, Plesner, T, Orlowski, R Z, Moreau, P, Bahlis, N, Basu, S, Nahi, H, Hulin, C, Quach, H, Goldschmidt, H, O'Dwyer, M, Perrot, A, Venner, C P, Weisel, K, Mace, J R, Raje, N, Tiab, M, Macro, M, Frenzel, L, Leleu, X, Ahmadi, T, Wang, J, Van Rampelbergh, R, Uhlar, C M, Tromp, B, Delioukina, M, Vermeulen, J & Usmani, S Z 2021, ' Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA) : overall survival results from a randomised, open-label, phase 3 trial ', The Lancet Oncology, vol. 22, no. 11, pp. 1582-1596 . https://doi.org/10.1016/S1470-2045(21)00466-6

مصطلحات موضوعية: Male, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Population, Dexamethasone, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Progression-free survival, education, Lenalidomide, Survival rate, Multiple myeloma, Aged, education.field_of_study, business.industry, Antibodies, Monoclonal, Daratumumab, Interim analysis, medicine.disease, Progression-Free Survival, Survival Rate, Transplantation, Oncology, Female, Multiple Myeloma, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec692d9ed7bfd495471f2523220cfb8b
https://doi.org/10.1016/s1470-2045(21)00466-6

المؤلفون: Saad Z. Usmani, Shaji Kumar, Torben Plesner, Robert Z. Orlowski, Philippe Moreau, Nizar J. Bahlis, Supratik Basu, Hareth Nahi, Cyrille Hulin, Hang Quach, Hartmut Goldschmidt, Michael E. O'Dwyer, Aurore Perrot, Chris P. Venner, Katja Weisel, Joseph R. Mace, Noopur S. Raje, Mourad Tiab, Margaret Macro, Laurent Frenzel, Xavier Leleu, Huiling Pei, Rian Van Rampelbergh, Brenda Tromp, Maria Delioukina, Thierry Facon

المصدر: Usmani, S Z, Kumar, S, Plesner, T, Orlowski, R Z, Moreau, P, Bahlis, N J, Basu, S, Nahi, H, Hulin, C, Quach, H, Goldschmidt, H, O'Dwyer, M E, Perrot, A, Venner, C P, Weisel, K, Mace, J R, Raje, N S, Tiab, M, Macro, M, Frenzel, L, Leleu, X, Pei, H, Van Rampelbergh, R, Tromp, B, Delioukina, M & Facon, T 2021, ' Efficacy of Daratumumab, Lenalidomide, and Dexamethasone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma and Impaired Renal Function from the Phase 3 Maia Study Based on Lenalidomide Starting Dose ', Blood, vol. 138, no. Suppl. 1, 1646 . https://doi.org/10.1182/blood-2021-146940

مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f9f03f36884b8e612f2e9301ce70667
https://portal.findresearcher.sdu.dk/da/publications/a08e2b73-7ce1-4f9b-89ae-8372d01183b1

المؤلفون: Cyrille Hulin, Christoph Heuck, Hartmut Goldschmidt, Lionel Karlin, Lauriane Clement-Filliatre, Shiyi Yang, Albert Oriol, Hila Magen, Mathias Haenel, Helen McCarthy, Paula Rodriguez-Otero, Philippe Moreau, Cyrille Touzeau, Kenshi Suzuki, Ajai Chari, Michele Kosh, Shinsuke Iida, Vladimir Maisnar, Maria Delioukina, Anna Sureda Balari, Luděk Pour, Vania Hungria

المصدر: Blood. 136:28-30

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Immunology, Daratumumab, Cell Biology, Hematology, Dara, medicine.disease, Biochemistry, Carfilzomib, chemistry.chemical_compound, Bortezomib/melphalan/prednisone, chemistry, Internal medicine, Cohort, medicine, business, Dexamethasone, Multiple myeloma, Lenalidomide, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::48efcb3f003d2340b8a3a5702e55407f
https://doi.org/10.1182/blood-2020-134935

المؤلفون: Helen McCarthy, Ajai Chari, Vladimir Maisnar, Hila Magen, Dolly A. Parasrampuria, Ming Qi, Shinsuke Iida, Vania Hungria, Aurore Perrot, Paula Rodriguez-Otero, Robin Carson, Cyrille Hulin, Ludek Pour, Kenshi Suzuki, Maria Delioukina, Anna Sureda Balari, Shiyi Yang, Tara Masterson, Cyrille Touzeau, Lionel Karlin, Michele Kosh

المصدر: Dipòsit Digital de la UB
Universidad de Barcelona

مصطلحات موضوعية: Melphalan, Adult, Male, Phases of clinical research, Dexamethasone, DOT 5, Bortezomib, 03 medical and health sciences, DOT 4, 0302 clinical medicine, DOT 3, Antineoplastic Agents, Immunological, Multiple myeloma, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Lenalidomide, Aged, Aged, 80 and over, business.industry, Mieloma múltiple, Daratumumab, Antibodies, Monoclonal, Standard of Care, Hematology, Middle Aged, medicine.disease, Combined Modality Therapy, Hematologic Diseases, Treatment Outcome, 030220 oncology & carcinogenesis, Prednisone, Monoclonal antibodies, Female, Immunotherapy, Nuclear medicine, business, Multiple Myeloma, Anticossos monoclonals, 030215 immunology, medicine.drug, Follow-Up Studies

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a34a7c70db01d1bec4e66a3ec39697d5
https://pubmed.ncbi.nlm.nih.gov/33216361

المؤلفون: Shaji Kumar, Katharine S. Gries, Laurent Frenzel, Michael O'Dwyer, Hartmut Goldschmidt, Aurore Perrot, Magaret Macro, Maria Delioukina, Cyrille Hulin, Chris Venner, Hareth Nahi, Brenda Tromp, Torben Plesner, Hang Quach, Kevin Liu, Nizar J. Bahlis, Supratik Basu, Jessica Vermeulen, John Fastenau, Xavier Leleu, Saad Z. Usmani, Kai Fai Ho, Mourad Tiab, Pankaj Mistry, Katja Weisel, Noopur Raje, Joseph R. Mace, Robert Z. Orlowski, Philippe Moreau, Thierry Facon

المصدر: Perrot, A, Facon, T, Kumar, S, Plesner, T, Orlowski, R Z, Moreau, P, Bahlis, N J, Basu, S, Nahi, H, Hulin, C, Quach, H, Goldschmidt, H, O'Dwyer, M E, Venner, C P, Weisel, K, Mace, J R, Raje, N S, Tiab, M, Macro, M, Frenzel, L, Leleu, X, Liu, K, Fastenau, J, Gries, K S, Ho, K F, Mistry, P, Tromp, B, Delioukina, M, Vermeulen, J & Usmani, S Z 2021, ' Meaningful Changes in Patient-Reported Outcomes in Relation to Best Clinical Response and Disease Progression : Post Hoc Analyses from MAIA ', Blood, vol. 138, no. Suppl. 1, 4095 . https://doi.org/10.1182/blood-2021-150369

مصطلحات موضوعية: medicine.medical_specialty, Post hoc, Relation (database), business.industry, Internal medicine, Immunology, Disease progression, medicine, In patient, Cell Biology, Hematology, business, Biochemistry

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e39fb8beb1fde49685e379c18c4cbd22
https://doi.org/10.1182/blood-2021-150369

المؤلفون: Xavier Leleu, Supratik Basu, Saad Z. Usmani, Maria Delioukina, Robert Z. Orlowski, Hang Quach, Katja Weisel, Jessica Vermeulen, Kevin Liu, Pankaj Mistry, Philippe Moreau, Cyrille Hulin, Mourad Tiab, Torben Plesner, Shaji Kumar, Michael O'Dwyer, Hartmut Goldschmidt, Katharine S. Gries, Laurent Frenzel, Chris Venner, Aurore Perrot, John Fastenau, Brenda Tromp, Magaret Macro, Hareth Nahi, Thierry Facon, Joseph R. Mace, Kai Fai Ho, Noopur Raje, Nizar J. Bahlis

المصدر: Perrot, A, Facon, T, Kumar, S, Plesner, T, Orlowski, R Z, Moreau, P, Bahlis, N J, Basu, S, Nahi, H, Hulin, C, Quach, H, Goldschmidt, H, O'Dwyer, M E, Venner, C P, Weisel, K, Mace, J R, Raje, N S, Tiab, M, Macro, M, Frenzel, L, Leleu, X, Liu, K, Fastenau, J, Gries, K S, Ho, K F, Mistry, P, Tromp, B, Delioukina, M, Vermeulen, J & Usmani, S Z 2021, ' Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone : Update of the Phase 3 MAIA Trial ', Blood, vol. 138, no. Suppl. 1, 1655 . https://doi.org/10.1182/blood-2021-144421

مصطلحات موضوعية: Health related quality of life, Oncology, medicine.medical_specialty, business.industry, Immunology, Daratumumab, Cell Biology, Hematology, Newly diagnosed, medicine.disease, Biochemistry, Transplant ineligible, Internal medicine, Medicine, business, Multiple myeloma, Dexamethasone, Lenalidomide, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3b967409a0946fad3fc6d9ba7892b94
https://doi.org/10.1182/blood-2021-144421

المؤلفون: Torben Plesner, Xavier Leleu, Supratik Basu, Noopur Raje, Joseph R. Mace, Saad Z. Usmani, Maria Delioukina, Hang Quach, Hartmut Goldschmidt, Huiling Pei, Shaji Kumar, Katja Weisel, Philippe Moreau, Thierry Facon, Christopher P. Venner, Nizar J. Bahlis, Laurent Frenzel, Mourad Tiab, Robert Z. Orlowski, Aurore Perrot, Cyrille Hulin, Michael O'Dwyer, Margaret Macro, Hareth Nahi, Brenda Tromp

المصدر: Clinical Lymphoma Myeloma and Leukemia. 21:S1

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, business.industry, Daratumumab, Hematology, Neutropenia, medicine.disease, Gastroenterology, Transplantation, Autologous stem-cell transplantation, Oncology, Internal medicine, medicine, Clinical endpoint, Progression-free survival, business, Multiple myeloma, Lenalidomide, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::862b8c17731181036f31798a6173e83c
https://doi.org/10.1016/s2152-2650(21)02075-9